CIGNA Declares Dividend and Increases Share Repurchase Authority

PHILADELPHIA--(BUSINESS WIRE)-- On February 23, 2011, the board of directors of CIGNA Corporation (NYSE: CI) declared an annual dividend of $0.04 per common share. The dividend is payable on April 11, 2011, to shareholders of record as of March 11, 2011.

In addition, CIGNA's board increased the company's stock repurchase authority by $500 million. With the new authority, CIGNA has approximately $675 million of share repurchase authority remaining.

About CIGNA

CIGNA (NYSE: CI) is a global health service and financial company dedicated to helping people improve their health, well-being and sense of security. CIGNA Corporation's operating subsidiaries in the United States provide an integrated suite of health services, such as medical, dental, behavioral health, pharmacy and vision care benefits, as well as group life, accident and disability insurance. CIGNA offers products and services in over 27 countries and jurisdictions and has approximately 65 million customer relationships throughout the world. All products and services are provided exclusively by such operating subsidiaries and not by CIGNA Corporation. Such operating subsidiaries include Life Insurance Company of North America, CIGNA Life Insurance Company of New York, and Connecticut General Life Insurance Company.

To learn more about CIGNA, visit www.cigna.com. To sign up for email alerts or an RSS feed of company news, log on to http://newsroom.cigna.com/rss.

Also, follow us on Twitter at @cigna, visit CIGNA’s YouTube channel at http://www.youtube.com/cigna and listen to CIGNA's podcast series with healthy tips and information at http://www.cigna.com/podcasts or by searching "CIGNA" in iTunes.



CONTACT:

CIGNA
Joseph Mondy, 860-226-5499
[email protected]

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Health  Professional Services  Insurance  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

The Centers for Medicare & Medicaid Services released the MA plan star ratings for the 2020 plan year on Friday.

A New Orleans-based genetic testing company will pay $42.6 million to resolve False Claims Act and kickback allegations.

A three-judge appellate panel didn't appear convinced that Medicaid work requirements meet the law's objectives of providing coverage.